pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Pulmonology · news · pharmadog
← back to Pulmonology
News · Pulmonology
512
stories
17d
STAT+: Why do ‘never-smokers’ get lung cancer? In some cases, rare genetic variant may be a factor
stat
17d
Roche bets up to $1B to advance next-gen bispecifics with Dualitas
biospace
17d
Rare EGFR mutation increases lung cancer risk 62 times in never smokers
fiercebiotech
18d
Novartis halts TREM2 targeting ALS program in 4th trial stumble in a month
biospace
18d
STAT+: Sen. Warren demands to see Trump drug-pricing pharma contracts, accuses RFK Jr. of hiding them
stat
18d
FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival
biospace
18d
Novo explores macrocycles’ potential in $1.4B cardiometabolic pact with Danish biotech
fiercebiotech
19d
WCLC ‘26: A new ‘ADC era,’ China questions and AstraZeneca’s spotlight
biopharma dive
19d
STAT+: RFK Jr. returns to his roots
stat
19d
STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseases
stat
19d
STAT+: Obesity drugmakers are testing in kids as young as 6
stat
19d
Despite 3 patient deaths, Cullinan-Taiho plan FDA filing for lung cancer pill on survival benefit
biospace
19d
GSK bags Chimagen’s trispecific T cell engager in deal worth up to $750M
biospace
19d
GSK lays off 650 staffers amid closure of German vaccine manufacturing site
biospace
19d
STAT+: Vera kidney drug Trutakna shows strong final results in Phase 3 trial
stat
19d
Connect's Dupixent rival flunks phase 2 asthma trial, but biotech sees reasons for hope
fiercebiotech
19d
J&J’s Contineum-partnered depression drug flunks another phase 2 test
fiercebiotech
20d
Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study results
biopharma dive
20d
Abbott agrees to settlement over closure of largest baby formula plant in the U.S.
stat
20d
BioNTech says CTLA-4 drug nearly doubled survival times for lung cancer
endpoints
20d
AstraZeneca’s newly approved pill fails frontline breast cancer study
biopharma dive
20d
STAT+: How $500 explains Republican health policy, and the GLP-1 Rx wave
stat
20d
Summit, BioNTech, more headline WCLC with next-gen lung cancer drugs
biospace
20d
GSK heads to FDA with recently acquired drug from Nuvalent
endpoints
20d
Electra aims for nearly $300M IPO; Enhertu's Phase 3 lung cancer success
endpoints
20d
Pennsylvania officials report state’s third death involving measles
stat
20d
STAT+: GSK touts lung cancer data from two drugs
stat
20d
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
biospace
20d
Scholar Rock SMA drug approved by FDA
biopharma dive
20d
Scholar Rock secures first FDA approval for muscle-targeting rare disease drug
biospace
← prev
page 3 of 18
next →
